BioSpace News Archive

Diaceutics collaborating with HistoCyte Laboratories and Targos Molecular Pathology on world’s first diagnostic network for precision medicine, DXRX Partnerships will drive diagnostic testing standardization for a network of more than 2,500 labs worldwide First pilot of partnership focusing on PD-L1 testing which still lacks standardization globally DXRX – The Diagnostic Network™ to enable marketplace where labs, pharma and di

ViruShield Inc., a California-based company that creates groundbreaking products to mitigate against the emergence of COVID-19 through inventive design and state-of-the-art technology, announces the launch of the ViruShield Ghost™.

Hour-long live streaming event will feature celebrities, musical performances and special guest Shannen Doherty’s exclusive roundtable conversation with other survivors

IBH Population Health Solutions (Integrated Behavioral Health, Inc.), a national leader in behavioral health technology and services, announced the launch of its new Provider Clinical Data Analytics technology platform that uses artificial intelligence (AI) and machine learning to improve the quality and outcomes of talk therapy counseling.

On July 16 at 1:00 pm EDT, OPEN MINDS will host the web briefing, Strategic Planning For Post-Disruption Recovery & Sustainability, for executives of health and human service organizations.

Genobank.io, the first ever anonymous, privacy-preserving DNA extraction kit announced that it has reached $418,000 in crowdfunding from over 1,400 investors around the world.

PDS Biotech ramps up third infectious disease vaccine program, PDS0202 for influenza, following PDS0201 for tuberculosis and PDS0203 for COVID-19

Crocker Partners, one of the largest vertically integrated commercial real estate companies in the Southeastern United States, has hired Dr. Walter Okoroanyanwu, MD, MPH, MBA as their Director of Environmental Health.

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2020 financial results on Wednesday, August 5th, before the market opens.

CVD Equipment Corporation (NASDAQ: CVV ) today announced that its subsidiary, CVD Materials Corporation (CVDM), will together with Dymax Corporation and Keyence Corporation of America collaborate in an effort to accelerate the development of CVDM’s novel c-VACNT™ Extracorporeal Membrane Oxygenation (ECMO) platform. ECMO devices are used to add Oxygen and remove Carbon Dioxide from a blood stream during periods when